Clinical trial
Recovery-focused Acceptance and Commitment Therapy Combined With Ketamine (K-ACT) for Patients With Difficult-to-treat Depression: a Feasibility Study.
NCT07906496 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started January 2027. Interventional study, 50 participants (estimated). Lead sponsor University of British Columbia; Canada. Primary measures: Feasibility outcomes; Safety outcomes.
How it compares
1,166 similar trials: same condition (Major Depressive Disorder) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- Recovery-focused Acceptance and Commitment Therapy Combined With Ketamine (K-ACT) for Patients With Difficult-to-treat Depression: a Feasibility Study.
- Lead sponsor
- University of British Columbia
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 31, 2027
- Completion date
- June 30, 2028
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
MeSH condition names; the registry's own terms follow.
Registry terms: major depressive disorder (mdd)
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- All
- Minimum age
- 18 Years
- Healthy volunteers
- No
- Study type
- Interventional
- Sites
- 1
- Countries
- Canada
- Lead sponsor
- University of British Columbia
Arms
As registered; 1 arm.
| Arm | Type | Interventions |
|---|---|---|
| K-ACT Intervention | Experimental | K-ACT Intervention |
Primary endpoints
Registered primary outcome measures; 2 primary.
| Measure | Time frame |
|---|---|
| Feasibility outcomes | 18 months/end of study |
Show registry wordingRate of recruitment/total participants enrolled, treatment attendance (sessions attended), retention, and follow-up completion | |
| Safety outcomes | 18 months/end of study |
Show registry wordingParticipant safety will be monitored through routine clinical assessments, including ongoing evaluation of suicidality and adverse events. | |
Lead sponsor's other trials
University of British Columbia, most recent start first.
+1,334 more trials See the organization page
Similar trials
Same condition (Major Depressive Disorder) and phase, most recent start first.
+1,161 more trials See the condition page